Angela Sciandivasci

785 total citations
23 papers, 593 citations indexed

About

Angela Sciandivasci is a scholar working on Oncology, Cancer Research and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Angela Sciandivasci has authored 23 papers receiving a total of 593 indexed citations (citations by other indexed papers that have themselves been cited), including 22 papers in Oncology, 14 papers in Cancer Research and 9 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Angela Sciandivasci's work include Breast Cancer Treatment Studies (10 papers), Cancer Treatment and Pharmacology (8 papers) and HER2/EGFR in Cancer Research (7 papers). Angela Sciandivasci is often cited by papers focused on Breast Cancer Treatment Studies (10 papers), Cancer Treatment and Pharmacology (8 papers) and HER2/EGFR in Cancer Research (7 papers). Angela Sciandivasci collaborates with scholars based in Italy, United States and Curacao. Angela Sciandivasci's co-authors include Elisabetta Munzone, Franco Nolè, Giuseppe Curigliano, Gaetano Aurilio, Laura Adamoli, Aron Goldhirsch, Giancarlo Pruneri, Giuseppe Viale, Vincenzo Bagnardi and Davide Disalvatore and has published in prestigious journals such as Journal of Clinical Oncology, Scientific Reports and British Journal of Cancer.

In The Last Decade

Angela Sciandivasci

22 papers receiving 579 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Angela Sciandivasci Italy 11 425 286 191 100 85 23 593
F. De Vita Italy 11 405 1.0× 220 0.8× 196 1.0× 198 2.0× 85 1.0× 37 691
Irene De Santo Italy 9 394 0.9× 213 0.7× 342 1.8× 169 1.7× 44 0.5× 13 692
Patricia Gómez Spain 8 486 1.1× 257 0.9× 182 1.0× 155 1.6× 88 1.0× 16 653
Massimo Rinaldo Italy 15 307 0.7× 299 1.0× 104 0.5× 98 1.0× 160 1.9× 29 690
Nobue Kumaki Japan 14 300 0.7× 201 0.7× 144 0.8× 135 1.4× 42 0.5× 47 600
Alexandre Bodmer Switzerland 14 344 0.8× 259 0.9× 94 0.5× 177 1.8× 105 1.2× 49 692
Reshma Mahtani United States 14 438 1.0× 194 0.7× 229 1.2× 142 1.4× 110 1.3× 80 630
Monica Milano Italy 10 311 0.7× 176 0.6× 138 0.7× 134 1.3× 83 1.0× 22 489
Gennaro Limite Italy 11 392 0.9× 320 1.1× 80 0.4× 146 1.5× 65 0.8× 32 674
Tomoyuki Aruga Japan 13 230 0.5× 161 0.6× 132 0.7× 71 0.7× 33 0.4× 59 403

Countries citing papers authored by Angela Sciandivasci

Since Specialization
Citations

This map shows the geographic impact of Angela Sciandivasci's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Angela Sciandivasci with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Angela Sciandivasci more than expected).

Fields of papers citing papers by Angela Sciandivasci

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Angela Sciandivasci. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Angela Sciandivasci. The network helps show where Angela Sciandivasci may publish in the future.

Co-authorship network of co-authors of Angela Sciandivasci

This figure shows the co-authorship network connecting the top 25 collaborators of Angela Sciandivasci. A scholar is included among the top collaborators of Angela Sciandivasci based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Angela Sciandivasci. Angela Sciandivasci is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Montagna, Emilia, Antonella Palazzo, Patrick Maisonneuve, et al.. (2017). Safety and efficacy study of metronomic vinorelbine, cyclophosphamide plus capecitabine in metastatic breast cancer: A phase II trial. Cancer Letters. 400. 276–281. 32 indexed citations
2.
Richichi, Cristina, Lorenzo Fornasari, Giorgio Melloni, et al.. (2017). Mutations targeting the coagulation pathway are enriched in brain metastases. Scientific Reports. 7(1). 9 indexed citations
3.
Munzone, Elisabetta, Cecilia Casali, Gaetano Aurilio, et al.. (2016). ecancermedicalscience. ecancermedicalscience. 7. 309–309. 1 indexed citations
4.
Munzone, Elisabetta, Vincenzo Bagnardi, Nicole Rotmensz, et al.. (2014). Prognostic relevance of peritumoral vascular invasion in immunohistochemically defined subtypes of node-positive breast cancer. Breast Cancer Research and Treatment. 146(3). 573–582. 10 indexed citations
5.
Aurilio, Gaetano, Lorenzo Monfardini, Stefania Rizzo, et al.. (2013). Discordant hormone receptor and human epidermal growth factor receptor 2 status in bone metastases compared to primary breast cancer. Acta Oncologica. 52(8). 1649–1656. 55 indexed citations
6.
Aurilio, Gaetano, Davide Disalvatore, Giancarlo Pruneri, et al.. (2013). A meta-analysis of oestrogen receptor, progesterone receptor and human epidermal growth factor receptor 2 discordance between primary breast cancer and metastases. European Journal of Cancer. 50(2). 277–289. 199 indexed citations
7.
Botteri, Edoardo, Elisabetta Munzone, Mattia Intra, et al.. (2013). Role of breast surgery in T1-3 breast cancer patients with synchronous bone metastases. Breast Cancer Research and Treatment. 138(1). 303–310. 5 indexed citations
8.
Munzone, Elisabetta, Edoardo Botteri, Maria Teresa Sandri, et al.. (2012). Prognostic Value of Circulating Tumor Cells According to Immunohistochemically Defined Molecular Subtypes in Advanced Breast Cancer. Clinical Breast Cancer. 12(5). 340–346. 38 indexed citations
9.
Munzone, Elisabetta, Edoardo Botteri, Alessandro Esposito, et al.. (2012). Outcome and clinical–biological characteristics of patients with advanced breast cancer undergoing removal of ovarian/pelvic metastases. Annals of Oncology. 23(11). 2884–2890. 1 indexed citations
10.
Munzone, Elisabetta, Edoardo Botteri, Angela Sciandivasci, et al.. (2012). Prognostic value of Ki-67 labeling index in patients with node-negative, triple-negative breast cancer. Breast Cancer Research and Treatment. 134(1). 277–282. 54 indexed citations
11.
Aurilio, Gaetano, Elisabetta Munzone, Edoardo Botteri, et al.. (2012). Oral Metronomic Cyclophosphamide and Methotrexate Plus Fulvestrant in Advanced Breast Cancer Patients: A Mono-Institutional Case-Cohort Report. The Breast Journal. 18(5). 470–474. 28 indexed citations
12.
Espósito, Angela, Elisabetta Munzone, Vincenzo Bagnardi, et al.. (2012). Are there benefits in routine clinical practice of continuing trastuzumab after progression for metastatic breast cancer patients?. Anti-Cancer Drugs. 23(10). 1089–1098. 6 indexed citations
13.
Aurilio, Gaetano, Angela Sciandivasci, Elisabetta Munzone, et al.. (2012). Prognostic value of circulating tumor cells in primary and metastatic breast cancer. Expert Review of Anticancer Therapy. 12(2). 203–214. 14 indexed citations
14.
Munzone, Elisabetta, Edoardo Botteri, Angela Sciandivasci, et al.. (2011). Prognostic significance of Ki-67 in node-negative (pN0), triple-negative (TN) breast cancer (BC).. Journal of Clinical Oncology. 29(15_suppl). 1056–1056. 1 indexed citations
15.
Correale, Pierpaolo, Francesca Montagnani, Angela Sciandivasci, et al.. (2008). Biweekly Triple Combination Chemotherapy with Gemcitabine, Oxaliplatin, Levofolinic Acid and 5-Fluorouracil (GOLF) Is a Safe and Active Treatment for Patients with Inoperable Pancreatic Cancer. Journal of Chemotherapy. 20(1). 119–125. 8 indexed citations
16.
Petrioli, Roberto, Edoardo Francini, Stefania Marsili, et al.. (2007). Weekly high‐dose calcitriol and docetaxel in patients with metastatic hormone‐refractory prostate cancer previously exposed to docetaxel. British Journal of Urology. 100(4). 775–779. 25 indexed citations
17.
Petrioli, Roberto, Edoardo Francini, Stefania Marsili, et al.. (2007). Neurotoxicity of FOLFOX-4 as adjuvant treatment for patients with colon and gastric cancer: a randomized study of two different schedules of oxaliplatin. Cancer Chemotherapy and Pharmacology. 61(1). 105–111. 43 indexed citations
18.
Correale, Pierpaolo, Angela Sciandivasci, Chiara Intrivici, et al.. (2007). Chemo-hormone therapy of non-well-differentiated endocrine tumours from different anatomic sites with cisplatinum, etoposide and slow release lanreotide formulation. British Journal of Cancer. 96(9). 1343–1347. 13 indexed citations
19.
Petrioli, Roberto, Edoardo Francini, Stefania Marsili, et al.. (2007). Capecitabine as third-line treatment in patients with metastatic renal cell carcinoma after failing immunotherapy. Anti-Cancer Drugs. 18(7). 817–820. 7 indexed citations
20.
Correale, Pierpaolo, Daniela Cerretani, Cinzia Remondo, et al.. (2006). A novel metronomic chemotherapy regimen of weekly platinum and daily oral etoposide in high-risk non-small cell lung cancer patients. Oncology Reports. 16(1). 133–40. 42 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by F. De Vita Breakdown of academic impact, for papers by Irene De Santo Breakdown of academic impact, for papers by Patricia Gómez Breakdown of academic impact, for papers by Massimo Rinaldo Breakdown of academic impact, for papers by Nobue Kumaki Breakdown of academic impact, for papers by Alexandre Bodmer Breakdown of academic impact, for papers by Reshma Mahtani Breakdown of academic impact, for papers by Monica Milano Breakdown of academic impact, for papers by Gennaro Limite Breakdown of academic impact, for papers by Tomoyuki Aruga
Rankless by CCL
2026